| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $3.0M | — | +10.5% |
| Cost of Revenue | $1.9M | — | +26.5% |
| Gross Profit | $1.1M | — | -9.9% |
| R&D Expense | $668K | — | -28.1% |
| SG&A Expense | $2.6M | — | +69.5% |
| Operating Income | -$4.2M | — | -14.5% |
| Pre-tax Income | -$4.1M | — | +4.2% |
| Income Tax | $0 | — | — |
| Net Income | -$4.1M | — | +4.2% |
| EPS (Basic) | -$1.77 | — | -608.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $4.2M | -70.6% | +466.3% |
| Short-term Investments | $7.1M | — | — |
| Accounts Receivable | $2.6M | +7.0% | +2.2% |
| Current Assets | $15.6M | -14.3% | +265.3% |
| Total Assets | $19.5M | -10.8% | +99.3% |
| Current Liabilities | $4.8M | +15.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | -14.5% |
| Investing Cash Flow | -$7.6M | — | -2798.6% |
| Financing Cash Flow | $0 | — | -100.0% |
| -62.6% |
| Total Liabilities | $5.0M | +14.4% | -62.6% |
| Stockholders' Equity | $14.5M | -17.1% | +520.2% |